Procalcitonin at the onset of giant cell arteritis and polymyalgia rheumatica: The GRACG prospective study

Rheumatology

Volumn 48, Issue 2, 2009, Pages 158-159

  Schmidt, Jean ^a   Duhaut, P ^a   Bourgeois, A M ^a   Salle, V ^a   Smail, A ^a   Chatelain, D ^a   Betsou, F ^a   Maziere J C ^a   Ducroix, J P ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Giant cell arteritis; Infectious trigger; Polymyalgia rheumatica; Procalcitonin

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN; STEROID;

AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GIANT CELL ARTERITIS; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATIC POLYMYALGIA; RISK FACTOR; SEX DIFFERENCE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; GIANT CELL ARTERITIS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; POLYMYALGIA RHEUMATICA; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SEX FACTORS; SMOKING;

EID: 58749091835     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken437     Document Type: Article

References (20)

1. Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J. Giant cell arteritis: Disease patterns of clinical presentation in a series of 240 patients. Medicine 2005;84:269-76.
2. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota: Apparent fluctuations in a cyclic pattern. Ann Intern Med 1995;123:192-4.
3. Elling P, Olsson AT, Elling H. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection. J Rheumatol 1996;23:112-9.
4. Weyand CM, Ma-Krupa W, Goronzy JJ. Immunopathways in giant cell arteritis and polymyalgia rheumatica. Autoimmun Rev 2004;3:46-53.
5. Ma-Krupa W, Kwan M, Goronzy JJ, Weyand CM. Toll-like receptors in giant cell arteritis. Clin Immunol 2005;115:38-46.
6. Schwarz S, Bertram M, Schwab S, Andrassy K, Hacke W. Serum procalcitonin levels in bacterial and abacterial meningitis. Crit Care Med 2000;28:1828-32.
7. Rau BM, Kemppainen EA, Gumbs AA et al. Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): A prospective international multicenter study. Ann Surg 2007;245:745-54.
8. Moosig F, Csernok E, Reinhold-Keller E, Schmitt W, Gross WL. Elevated procalcitonin levels in active Wegener's granulomatosis. J Rheumatol 1998;25: 1531-3.
9. Okada Y, Minakami H, Tomomasa T et al. Serum procalcitonin concentration in patients with Kawasaki disease. J Infect 2004;48:199-205.
10. Ilhan F, Akbulut H, Karaca I, Godekmerdan A, Ilkay E, Bulut V. Procalcitonin, c-reactive protein and neopterin levels in patients with coronary atherosclerosis. Acta Cardiol 2005;60:361-5.
11. Erren M, Reinecke H, Junker R et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 1999;19:2355-63.
12. Duhaut P, Pinède L, Demolombe-Rague S et al. Giant cell arteritis and cardiovascular risk factors: A multicenter, prospective case-control study. Groupe de Recherche sur l'Arté rite à Cellules Géantes. Arthritis Rheum 1998;41:1960-5.
13. Duhaut P, Berruyer M, Pinede L et al. Anticardiolipin antibodies and giant cell arteritis: A prospective, multicenter case-control study. Groupe de Recherche sur l'Arté rite à Cellules Géantes. Arthritis Rheum 1998;41:701-9.
14. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: A 10-year epidemiologic and clinical study. Ann Intern Med 1982;97:672-80.
15. Gonzalez-Gay MA, Garcia-Porrua C, Salvarani C, Olivieri I, Hunder GG. The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain. J Rheumatol 2000;27:2179-84.
16. Bazzano LA, He J, Muntner P, Vupputuri S, Whelton PK. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med 2003;138:891-7.
17. Delèvaux I, André M, Colombier M et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis 2003;62:337-40.
18. Quintana G, Medina YF, Rojas C et al. The use of procalcitonin determinations in evaluation of systemic lupus erythematosus. J Clin Rheumatol 2008;14:138-42.
19. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Gonzalez-Louzao C, Rodriguez-Ledo P. Biopsy-negative giant cell arteritis: Clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum 2001;30:249-56.
20. Duhaut P, Pinède L, Bornet H et al. Biopsy proven and biopsy negative temporal arteritis: Differences in clinical spectrum at the onset of the disease. Groupe de Recherche sur l'Artérite à Cellules Géantes. Ann Rheum Dis 1999; 58:335-41.